Literature DB >> 9643685

Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group.

E Tetteroo1, Y van der Graaf, J L Bosch, A D van Engelen, M G Hunink, B C Eikelboom, W P Mali.   

Abstract

BACKGROUND: Percutaneous transluminal angioplasty (PTA) is a safe, simple, and successful treatment for intermittent claudication caused by iliac-artery occlusive disease. Primary stent placement has been proposed as more effective than PTA. We compared the technical results and clinical outcomes of two treatment strategies-primary placement of a stent across the stenotic segment of the iliac artery, or primary PTA followed by selective stent placement when haemodynamic results were inadequate.
METHODS: We randomly assigned 279 patients with intermittent claudication, recruited from departments of vascular surgery, either to direct stent placement (group I, n=143) or primary angioplasty (group II, n=136), with subsequent stent placement in case of a residual mean pressure gradient greater than 10 mm Hg across the treated site. The main inclusion criterion was intermittent claudication on the basis of iliac-artery stenosis of more than 50%, proven by angiography. All patients had a clinical assessment before intervention and at 3, 12, and 24 months. Clinical success was defined as improvement of at least one clinical category. Secondary endpoints were initial technical results, procedural complications, cumulative patency as assessed by duplex ultrasonography, and quality of life.
FINDINGS: In group II, selective stent placement was done in 59 (43%) of the 136 patients. The mean follow-up was 9.3 months (range 3-24). Initial haemodynamic success and complication rates were 119 (81%) of 149 limbs and 6 (4%) of 143 limbs (group I) versus 103 (82%) of 126 limbs and 10 (7%) of 136 limbs (group II), respectively. Clinical success rates at 2 years were 29 (78%) of 37 patients and 26 (77%) of 34 patients in groups I and II, respectively (p=0.6); however, 43% and 35% of the patients, respectively, still had symptoms. Quality of life improved significantly after intervention (p<0.05) but we found no difference between the groups during follow-up. 2-year cumulative patency rates were similar at 71% versus 70% (p=0.2), respectively, as were reintervention rates at 7% versus 4%, respectively (95% CI -2% to 9%).
INTERPRETATION: There were no substantial differences in technical results and clinical outcomes of the two treatment strategies both at short-term and long-term follow-up. Since angioplasty followed by selective stent placement is less expensive than direct placement of a stent, the former seems to be the treatment of choice for lifestyle-limiting intermittent claudication caused by iliac artery occlusive disease.

Entities:  

Mesh:

Year:  1998        PMID: 9643685     DOI: 10.1016/s0140-6736(97)09508-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication.

Authors:  J L Bosch; M G Hunink
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

Review 2.  Non-cardiac vascular disease.

Authors:  Thomas W G Carrell; John H N Wolfe
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

3.  Percutaneous laser-assisted recanalization of long chronic iliac artery occlusions: primary and mid-term results.

Authors:  Jörn O Balzer; Verena Gastinger; Axel Thalhammer; Ralf G Ritter; Edelgard Lindhoff-Last; Thomas Schmitz-Rixen; Thomas J Vogl
Journal:  Eur Radiol       Date:  2005-04-14       Impact factor: 5.315

Review 4.  [Rational minimally invasive treatment of pAOD: when should a conservative approach, PTA, or stent be chosen?].

Authors:  S Müller-Hülsbeck
Journal:  Radiologe       Date:  2006-11       Impact factor: 0.635

Review 5.  Peripheral arterial disease.

Authors:  Kevin Cassar
Journal:  BMJ Clin Evid       Date:  2007-07-01

Review 6.  Endovascular intervention for peripheral artery disease.

Authors:  Arun K Thukkani; Scott Kinlay
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

Review 7.  [Peripheral vascular disease of iliac and femoro-popliteal arteries: state-of-the-art endoluminal revascularization].

Authors:  A Chavan; L Luthe; B Schmuck
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

Review 8.  Peripheral arterial disease.

Authors:  Kevin Cassar
Journal:  BMJ Clin Evid       Date:  2011-01-11

Review 9.  [Surgical management of peripheral arterial disease. Operative methods and results].

Authors:  B Wulff; T Jungbluth; H Esnaashari; C Franke; H-P Bruch
Journal:  Radiologe       Date:  2006-11       Impact factor: 0.635

10.  Mid-term outcomes following endovascular re-intervention for iliac artery in-stent restenosis.

Authors:  Usman Javed; Christopher R Balwanz; Ehrin J Armstrong; Khung-Keong Yeo; Gagan D Singh; Satinder Singh; David Anderson; Gregory G Westin; William C Pevec; John R Laird
Journal:  Catheter Cardiovasc Interv       Date:  2013-05-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.